Compound class:
Synthetic organic
Comment: OD36-induced inhibition of RIPK2 produces anti-inflammatory activity in animal models of inflammatory bowel conditions [1].
Ligand Activity Visualisation ChartsThese are box plot that provide a unique visualisation, summarising all the activity data for a ligand taken from ChEMBL and GtoPdb across multiple targets and species. Click on a plot to see the median, interquartile range, low and high data points. A value of zero indicates that no data are available. A separate chart is created for each target, and where possible the algorithm tries to merge ChEMBL and GtoPdb targets by matching them on name and UniProt accession, for each available species. However, please note that inconsistency in naming of targets may lead to data for the same target being reported across multiple charts. ✖ |
|
Bioactivity Comments |
In a kinase screening panel of 366 kinases, 100 nM OD36 inhibited several kinases by >50% (RIPK2 97%, ALK2 95%, SIK2 94%, ACVR2B 90%, ACVRL1 88%, ZAK 70%, TGFBR2 68%, DDR2 59%, FYN 59%, CDK8/cyclin C 57% [1]. The inhibition profile of OD36 differs from that of gefitinib (inhibits RIPK2 by 96% at 1μM), which facilitates idenification of RIPK2-mediated effects from those caused by inhibition of off-target kinases. |
Selectivity at enzymes | ||||||||||||||||||||||||||||||||||
Key to terms and symbols | Click column headers to sort | |||||||||||||||||||||||||||||||||
|